We are live on ! Find out more
NUS icon

Nu Skin

212 hedge funds and large institutions have $794M invested in Nu Skin in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 84 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.71% more ownership

Funds ownership: 82.1%82.8% (+0.71%)

0% more funds holding

Funds holding: 212212 (0)

0% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 32

9% less capital invested

Capital invested by funds: $870M → $794M (-$75.6M)

21% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 84

53% less call options, than puts

Call options by funds: $1.94M | Put options by funds: $4.17M

Holders
212
Holders Change
Holders Change %
0%
% of All Funds
3.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
66
Reduced
84
Closed
32
Calls
$1.94M
Puts
$4.17M
Net Calls
-$2.22M
Net Calls Change
-$1.98M

NUS Hedge Fund Activity: Q4 2023 in Review

212 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Nu Skin (NUS) for Q4 2023, worth a combined $794M — down 8.7% from $870M a quarter earlier.

Fund positioning in NUS was balanced in Q4 2023: 32 funds opened new positions, 32 closed out, 66 added to existing stakes and 84 trimmed.

The largest buyer was Invesco, adding an estimated $21.5M. The largest seller was Marshall Wace, cutting an estimated $16.4M.

  • 212 institutional investors held Nu Skin (NUS) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $794M of Nu Skin stock for Q4 2023, down 8.7% quarter-over-quarter.
  • 32 funds opened new Nu Skin positions in Q4 2023 and 32 closed out, a net change of 0 holders.
  • The largest Nu Skin buyer in Q4 2023 was Invesco, an estimated $21.5M added.
  • The largest Nu Skin seller in Q4 2023 was Marshall Wace, an estimated $16.4M sold.

Based on aggregated 13F filings for Q4 2023.